RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 116 filers reported holding RAPT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $7,574,000 | – | 238,246 | – | 2.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $49,189,395 | 17.79% |
| Euclidean Capital LLC | 432,900 | $7,943,715 | 6.97% |
| GREAT POINT PARTNERS LLC | 1,355,151 | $24,867,021 | 4.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 875,984 | $16,074,306 | 3.02% |
| Trustees of Columbia University in the City of New York | 80,580 | $1,478,643 | 2.64% |
| Perceptive Advisors | 2,291,608 | $42,051,007 | 1.24% |
| Cormorant Asset Management, LP | 650,000 | $11,928 | 0.79% |
| Alphabet Inc. | 540,270 | $9,913,955 | 0.55% |
| Redmile Group, LLC | 688,132 | $12,627,222 | 0.55% |
| Orbimed Advisors | 1,251,070 | $22,957,135 | 0.45% |